on news

footer news ticker

SUCCESSFUL PLACEMENT: REVANCE THERAPEUTICS

Mar 14, 2016 | Steve Cornacchia, Successful Placements

REVANCE THERAPEUTICS EXPANDS LEADERSHIP TEAM, APPOINTS ROMAN G. RUBIO, MD, MBA, AS SENIOR VICE PRESIDENT OF CLINICAL DEVELOPMENT

NEWARK, Calif., March 14, 2016 (GLOBE NEWSWIRE) — Revance Therapeutics, Inc. (NASDAQ:RVNC), a biotechnology company developing botulinum toxin products for use in aesthetic and therapeutic indications, today announced a key addition to its leadership team with the appointment of Roman G. Rubio, MD, MBA, as Senior Vice President of Clinical Development, effective immediately. Dr. Rubio will report to Chief Operating Officer Abhay Joshi, and will lead the company’s clinical development team, focusing on further accelerating the advancement of Revance’s neurotoxin development programs. Read the full release

Archives

+

connect with ON.

Bring ON executive search insights!
Sign up to receive thought leadership pieces, ON in the news, recent placements, quarterly updates and more.

ON resources.

ON in the news

ON successful placements

recognition of ON.

Top 20 Ranking

Top 20 Executive Search Firm

2019 Fastest Growing Companies

ANNAPOLIS • ATLANTA • BOSTON • CLEVELAND • DALLAS • MENLO PARK • MINNEAPOLIS • NEW YORK • SAN FRANCISCO

© Copyright 2019 On Partners. All Rights Reserved.